Eisai Co., Ltd. (TYO:4523)

Revenue by Segment

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Pharmaceutical Business - Japan (Including Pharmaceutical Business - OTC and Others)	229.24B	216.28B	216.94B	-	-
Pharmaceutical Business - Americas	300.44B	278.26B	232.38B	212.74B	172.02B
Pharmaceutical Business - China	130.75B	115.54B	111.93B	110.77B	106.42B
Pharmaceutical Business - EMEA	81.53B	79.40B	75.99B	72.16B	59.34B
Pharmaceutical Business - East Asia Global South	68.82B	59.56B	54.23B	49.84B	50.63B
Other Business	14.60B	40.37B	50.29B	59.97B	129.95B
Pharmaceutical Business - Japan (Excl. Pharmaceutical Business - OTC Drugs)	-	-	-	215.42B	214.05B
Pharmaceutical Business - OTC and Others	-	-	-	23.51B	23.83B
Total	825.38B	789.40B	741.75B	744.40B	756.23B

Revenue by Geography

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017
Europe	70.99B	74.29B	90.53B	86.03B	126.75B
Others	80.04B	72.31B	61.74B	60.20B	52.78B
Japan	237.03B	228.73B	226.45B	250.33B	243.39B
United States (U.S.)	293.14B	272.99B	243.14B	231.36B	172.50B
Americas (Excluding United States)	16.95B	13.59B	10.61B	7.94B	54.22B
China	127.24B	127.49B	109.28B	108.56B	106.59B
Total	825.38B	789.40B	741.75B	744.40B	756.23B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 4, 2026

Data Sources Report a data error